Caroline Graettinger, left, and Taitia Shelow, both of Cecil Township, have been diagnosed with scleroderma, a rare autoimmune disease that causes hardening and thickening of the skin and other organs ...
Angiotensin-converting enzyme (ACE) inhibitors are the mainstay of therapy for patients with systemic sclerosis in scleroderma renal crisis, however mortality remains high even in the post-ACE ...
Please provide your email address to receive an email when new articles are posted on . Injections yielded significant improvements in visual analog scale pain and Quick-DASH score, as well as skin ...
What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...
Following the 2017 American College of Rheumatology (ACR) Annual Meeting—held in San Diego, California, November 3-8—Medscape spoke with Hospital for Special Surgery rheumatologists Dr Robert F.
Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology. Characterized by ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Kelly Burch Every time Kelly publishes a story, you’ll get an alert straight to your inbox!
Sanofi will be the inaugural partner for the Scleroderma Research Foundation’s new clinical trial initiative to advance treatments for the rare autoimmune disorder of the skin and organs. The ...
Scleroderma is an autoimmune, rheumatic, and chronic disease that affects the body by hardening connective tissue, according to the Johns Hopkins Scleroderma Center. For the almost 500,000 people in ...
More collagen in the human body is not always good, and Karin Wuertz-Kozak is investigating how disease progresses because of the increase in this important protein. Wuertz-Kozak recently received ...
Add Yahoo as a preferred source to see more of our stories on Google. RED OAK — Today was a TOUGH day. That's how Barb Heenan described Day 1 of RAGBRAI. But the 53-year-old from Des Moines was ready ...
The Scleroderma Research Foundation (SRF) — the country’s first and leading nonprofit investor in medical research into scleroderma — announced the lineup for its annual Cool Comedy • Hot Cuisine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results